Metabolic and Bariatric Surgery for Obesity.

Authors :: Vidal J
Corcelles R
Jiménez A
Flores L
Lacy AM
Source :: Gastroenterology [Gastroenterology] 2017 May; Vol. 152 (7), pp. 1780-1790. Date of Electronic Publication: 2017 Feb 11.
Publication Year :: 2017
Abstract: Metabolic and bariatric surgery (MBS) leads to weight loss in obese individuals and reduces comorbidities such as type 2 diabetes. MBS is superior to medical therapy in reducing hyperglycemia in persons with type 2 diabetes, and has been associated with reduced mortality and incidences of cardiovascular events and cancer in obese individuals. New guidelines have been proposed for the use of MBS in persons with type 2 diabetes. We review the use of MBS as a treatment for obesity and obesity-related conditions and, based on recent evidence, propose that health care systems make the appropriate changes to increase accessibility for eligible patients.<br /> (Copyright © 2017 AGA Institute. Published by Elsevier Inc. All rights reserved.)